Contraception and HRT prescribing in patients on GLP-1 agonist weight-loss drugs GP with an interest in womens health Dr Toni Hazell discusses the recent rise in the use of injectable GLP-1 receptor agonists for weight loss and the challenges this can pose when prescribing contraception or HRT GLP-1 agonists arent widely available on the NHS, so why is this a big issue
World Diabetes Day Reminder: Medication Is Only One Tool While semaglutide is powerful, diabetes management remains a whole-person journey
Participants were recruited from 23 clinical study centers in the United States between 31 July 1996 and 18 May 1999, and randomized to either LI or metformin or placebo groups
does not condone or promote the use of these compounds outside of legitimate research
Patients who are overweight (body mass index greater than 27)
It is crucial for healthcare professionals to prescribe and administer these anti-diabetic medications appropriately, considering factors like the patient's medical history, co-existing conditions, and potential drug interactions
